Swiss researchers used susceptibility-weighted MRI and an artificial intelligence technique to help identify which individuals with mild cognitive impairment will continue to decline.
Swiss researchers used susceptibility-weighted MRI and an artificial intelligence technique to help identify which individuals with mild cognitive impairment will continue to decline.
Susceptibility-weighted MRI measures magnetic susceptibility phase-effect differences between tissues. Using the technique, researchers were able to view details of the blood vessels in the brain, including microhemorrhages and microbleeds.
The scans revealed microbleeds in 33% subjects with stable mild cognitive impairment. They found microbleeds in 54% of those with progressive cognitive impairment and in 14% of the control group. The study appeared in Radiology.
The researchers also analyzed the data with support vector technology algorithms to identify patterns within a group and create classifications. By adding the support vector technology to the baseline MRI data the researchers were able to distinguish patients with mild cognitive impairment with 85% accuracy.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.